Search Results - "Humar, Atul"

Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS‐CoV‐2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4⁺ T‐Cell Activity.

Authors: Ferreira, Victor H. Keith, Brandon Mavandadnejad, Faranak et al.

Source: Transplant Infectious Disease. Jul2025, Vol. 27 Issue 4, p1-9. 9p.

Testing the delivery of human organ transportation with drones in the real world.

Authors: Sage, Andrew T. Cypel, Marcelo Cardinal, Mikael et al.

Source: Science Robotics; 12/14/2022, Vol. 7 Issue 73, p1-3, 3p

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.

Authors: Kabbani, Dima Yotis, Demitra M Ferreira, Victor H et al.

Source: Open Forum Infectious Diseases. May2023, Vol. 10 Issue 5, p1-8. 8p.

Acyl‐CoA Thioesterase 1 Contributes to Transition of Steatosis to Metabolic‐Associated Steatohepatitis.

Authors: Pasini, Elisa Baciu, Cristina Angeli, Marc et al.

Source: International Journal of Hepatology. 7/11/2024, Vol. 2024, p1-17. 17p.

Long Term Immune Responses to Pandemic Influenza A/H1N1 Infection in Solid Organ Transplant Recipients.

Authors: Baluch, Aliyah Humar, Atul Egli, Adrian et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 12, p1-6. 6p.

Management of refractory and resistant CMV: A step forward but more work needed.

Authors: Taha, Rbab Humar, Atul

Source: Transplant Infectious Disease. Aug2021, Vol. 23 Issue 4, p1-2. 2p.

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.

Authors: Kotton, Camille N. Torre‐Cisneros, Julián Aguado, José Maria et al.

Source: Transplant Infectious Disease. Dec2022, Vol. 24 Issue 6, p1-13. 13p.

Characterization and predictive functional profiles on metagenomic 16S rRNA data of liver transplant recipients: A longitudinal study.

Authors: Sivaraj, Saranya Copeland, Julia K. Malik, Anshu et al.

Source: Clinical Transplantation. Feb2022, Vol. 36 Issue 2, p1-11. 11p.

Organ utilization from increased infectious risk donors: An observational study.

Authors: L'Huillier, Arnaud G. Humar, Atul Payne, Clare et al.

Source: Transplant Infectious Disease. Dec2017, Vol. 19 Issue 6, pn/a-N.PAG. 7p.

The economic impact of increased length of stay associated with surgical site infections in liver transplantation on Canadian healthcare costs.

Authors: Natori, Yoichiro Vu, James Chow, Edwin et al.

Source: Clinical Transplantation. Jan2021, Vol. 35 Issue 1, p1-8. 8p.

Clinical predictors of progression and clearance of low‐level CMV DNAemia in solid organ transplant recipients.

Authors: Natori, Yoichiro Alghamdi, Ali Husain, Shahid et al.

Source: Transplant Infectious Disease. Feb2020, Vol. 22 Issue 1, p1-6. 6p.

Management of ganciclovir resistance cytomegalovirus infection with CMV hyperimmune globulin and leflunomide in seven cardiothoracic transplant recipients and literature review.

Authors: Santhanakrishnan, Karthik Yonan, Nizar Iyer, Kapil et al.

Source: Transplant Infectious Disease. Feb2022, Vol. 24 Issue 1, p1-11. 11p.

Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study.

Authors: Hall, Victoria G. Ferreira, Victor Kumar, Deepali et al.

Source: Transplant Infectious Disease. Dec2021, Vol. 23 Issue 6, p1-8. 8p.

Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial.

Authors: Humar, Atul Gill, John Johnston, Olwyn et al.

Source: Trials. 2013, Vol. 14 Issue 1, p1-6. 6p.

Late‐onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti‐CMV prophylaxis required following late‐onset allograft rejection?

Authors: Rahimishahmirzadi, Mohammadreza Jevnikar, Anthony M. House, Andrew A. et al.

Source: Clinical Transplantation. Jun2021, Vol. 35 Issue 6, p1-8. 8p.

Long‐lasting cluster of nosocomial pneumonia with a single Pneumocystis jirovecii genotype involving different organ allograft recipients.

Authors: Hosseini‐Moghaddam, Seyed M. Dufresne, Philippe J. Hunter Gutierrez, Elaine et al.

Source: Clinical Transplantation. Dec2020, Vol. 34 Issue 12, p1-8. 8p.

T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients.

Authors: L'Huillier, Arnaud G. Ferreira, Victor H. Hirzel, Cedric et al.

Source: Scientific Reports. 6/22/2020, Vol. 10 Issue 1, p1-9. 9p.

Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial.

Authors: Chruscinski, Andrzej Rojas-Luengas, Vanessa Moshkelgosha, Sajad et al.

Source: Clinical & Experimental Immunology. Jan2022, Vol. 207 Issue 1, p123-139. 17p.

Editorial Commentary: Understanding Risk and Enhancing Safety in Immunotherapy Trials.

Authors: Kumar, Deepali Humar, Atul

Source: Clinical Infectious Diseases. 1/15/2013, Vol. 56 Issue 2, p255-257. 3p.

Tuberculosis and Transplantation: Battling the Opportunist.

Authors: Kumar, Deepali Humar, Atul

Source: Clinical Infectious Diseases. 6/15/2009, Vol. 48 Issue 12, p1666-1668. 3p.